{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T15:21:59Z","timestamp":1772810519755,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s00417-025-07039-6","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T09:19:31Z","timestamp":1763716771000},"page":"679-688","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ethnic comparison of MacTel over 5 years follow up"],"prefix":"10.1007","volume":"264","author":[{"given":"Priyanka","family":"Gandhi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karishma","family":"Tendulkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soema","family":"Tehbla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pratibha","family":"Hande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vishma","family":"Prabhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramesh","family":"Venkatesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1772-3558","authenticated-orcid":false,"given":"Jay","family":"Chhablani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"key":"7039_CR1","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.preteyeres.2012.11.002","volume":"34","author":"P Charbel Issa","year":"2013","unstructured":"Charbel Issa P, Gillies MC, Chew EY et al (2013) Macular telangiectasia type 2. Prog Retin Eye Res 34:49\u201377. https:\/\/doi.org\/10.1016\/j.preteyeres.2012.11.002","journal-title":"Prog Retin Eye Res"},{"key":"7039_CR2","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.exer.2009.02.006","volume":"89","author":"P Charbel Issa","year":"2009","unstructured":"Charbel Issa P, van der Veen RLP, Stijfs A et al (2009) Quantification of reduced macular pigment optical density in the central retina in macular telangiectasia type 2. Exp Eye Res 89:25\u201331. https:\/\/doi.org\/10.1016\/j.exer.2009.02.006","journal-title":"Exp Eye Res"},{"key":"7039_CR3","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s12886-022-02483-y","volume":"22","author":"R Srinivasan","year":"2022","unstructured":"Srinivasan R, Teussink MM, Sloan KR et al (2022) Distribution of macular pigments in macular telangiectasia type 2 and correlation with optical coherence tomography characteristics and visual acuity. BMC Ophthalmol 22:264. https:\/\/doi.org\/10.1186\/s12886-022-02483-y","journal-title":"BMC Ophthalmol"},{"key":"7039_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s40942-016-0044-9","author":"VC Lima","year":"2016","unstructured":"Lima VC, Rosen RB, Farah M (2016) Macular pigment in retinal health and disease. Int J Retina Vitreous. https:\/\/doi.org\/10.1186\/s40942-016-0044-9","journal-title":"Int J Retina Vitreous"},{"key":"7039_CR5","doi-asserted-by":"publisher","DOI":"10.1177\/2515841420924167","volume":"12","author":"PG Davey","year":"2020","unstructured":"Davey PG, Lievens C, Ammono-Monney S (2020) Differences in macular pigment optical density across four ethnicities: a comparative study. Ther Adv Ophthalmol 12:2515841420924167. https:\/\/doi.org\/10.1177\/2515841420924167","journal-title":"Ther Adv Ophthalmol"},{"key":"7039_CR6","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ajo.2010.02.013","volume":"150","author":"R Klein","year":"2010","unstructured":"Klein R, Blodi BA, Meuer SM et al (2010) The prevalence of macular telangiectasia type 2 in the Beaver Dam eye study. Am J Ophthalmol 150:55-62.e2. https:\/\/doi.org\/10.1016\/j.ajo.2010.02.013","journal-title":"Am J Ophthalmol"},{"key":"7039_CR7","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/IAE.0b013e3181bd2c71","volume":"30","author":"KZ Aung","year":"2010","unstructured":"Aung KZ, Wickremasinghe SS, Makeyeva G et al (2010) The prevalence estimates of macular telangiectasia type 2: the Melbourne Collaborative Cohort Study. Retina 30:473\u2013478. https:\/\/doi.org\/10.1097\/IAE.0b013e3181bd2c71","journal-title":"Retina"},{"key":"7039_CR8","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3109\/09286586.2012.654844","volume":"19","author":"EY Chew","year":"2012","unstructured":"Chew EY (2012) How prevalent is macular telangiectasia type 2? Ophthalmic Epidemiol 19:183\u2013184. https:\/\/doi.org\/10.3109\/09286586.2012.654844","journal-title":"Ophthalmic Epidemiol"},{"key":"7039_CR9","doi-asserted-by":"publisher","first-page":"830","DOI":"10.4103\/ijo.IJO_85_17","volume":"65","author":"A Elias","year":"2017","unstructured":"Elias A, Gopalakrishnan M, Anantharaman G (2017) Risk factors in patients with macular telangiectasia 2A in an Asian population: a case\u2013control study. Indian J Ophthalmol 65:830. https:\/\/doi.org\/10.4103\/ijo.IJO_85_17","journal-title":"Indian J Ophthalmol"},{"key":"7039_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s40942-017-0103-x","volume":"3","author":"M Jhingan","year":"2017","unstructured":"Jhingan M, Marsonia K, Shukla D et al (2017) Idiopathic macular telangiectasis type 2 and co-existent diabetic retinopathy. Int J Retina Vitreous 3:50. https:\/\/doi.org\/10.1186\/s40942-017-0103-x","journal-title":"Int J Retina Vitreous"},{"key":"7039_CR11","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3109\/09286586.2013.766757","volume":"20","author":"TE Clemons","year":"2013","unstructured":"Clemons TE, Gillies MC, Chew EY et al (2013) Medical characteristics of patients with macular telangiectasia type 2 (MacTel type 2) MacTel project report no. 3. Ophthalmic Epidemiol 20:109\u2013113. https:\/\/doi.org\/10.3109\/09286586.2013.766757","journal-title":"Ophthalmic Epidemiol"},{"key":"7039_CR12","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.visres.2017.03.013","volume":"139","author":"BA Coughlin","year":"2017","unstructured":"Coughlin BA, Feenstra DJ, Mohr S (2017) M\u00fcller cells and diabetic retinopathy. Vis. Res 139:93\u2013100. https:\/\/doi.org\/10.1016\/j.visres.2017.03.013","journal-title":"Vis. Res"},{"key":"7039_CR13","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1016\/j.ophtha.2013.04.013","volume":"120","author":"MB Powner","year":"2013","unstructured":"Powner MB, Gillies MC, Zhu M et al (2013) Loss of M\u00fcller\u2019s cells and photoreceptors in macular telangiectasia type 2. Ophthalmology 120:2344\u20132352. https:\/\/doi.org\/10.1016\/j.ophtha.2013.04.013","journal-title":"Ophthalmology"},{"key":"7039_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s40942-022-00378-0","volume":"8","author":"R Venkatesh","year":"2022","unstructured":"Venkatesh R, Reddy NG, Mishra P et al (2022) Spectral domain OCT features in type 2 macular telangiectasia (type 2 MacTel): its relevance with clinical staging and visual acuity. Int J Retina Vitreous 8:26. https:\/\/doi.org\/10.1186\/s40942-022-00378-0","journal-title":"Int J Retina Vitreous"},{"key":"7039_CR15","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.12-9756","volume":"53","author":"SD Esposti","year":"2012","unstructured":"Esposti SD, Egan C, Bunce C et al (2012) Macular pigment parameters in patients with macular telangiectasia (MacTel) and normal subjects: implications of a novel analysis. Investigative Opthalmology & Visual Science 53:6568. https:\/\/doi.org\/10.1167\/iovs.12-9756","journal-title":"Investigative Opthalmology & Visual Science"},{"key":"7039_CR16","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1097\/IAE.0000000000000023","volume":"34","author":"MB Zeimer","year":"2014","unstructured":"Zeimer MB, Spital G, Heimes B et al (2014) Macular telangiectasia\u2013changes in macular pigment optical density during a 5-year follow-up. Retina 34:920\u2013928. https:\/\/doi.org\/10.1097\/IAE.0000000000000023","journal-title":"Retina"},{"key":"7039_CR17","doi-asserted-by":"publisher","first-page":"477","DOI":"10.4103\/ijo.IJO_365_16","volume":"65","author":"A Ozyurt","year":"2017","unstructured":"Ozyurt A, Kocak N, Akan P et al (2017) Comparison of macular pigment optical density in patients with dry and wet age-related macular degeneration. Indian J Ophthalmol 65:477\u2013481. https:\/\/doi.org\/10.4103\/ijo.IJO_365_16","journal-title":"Indian J Ophthalmol"},{"key":"7039_CR18","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1136\/bjo.83.7.867","volume":"83","author":"S Beatty","year":"1999","unstructured":"Beatty S, Boulton M, Henson D et al (1999) Macular pigment and age related macular degeneration. Br J Ophthalmol 83:867\u2013877. https:\/\/doi.org\/10.1136\/bjo.83.7.867","journal-title":"Br J Ophthalmol"},{"key":"7039_CR19","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1080\/08820538.2021.1929347","volume":"37","author":"K Marsonia","year":"2022","unstructured":"Marsonia K, Kiran Chandra K, Ali MH et al (2022) Long term follow-up of visual acuity and incidence of subretinal neovascularization in Mactel type 2 in 82 eyes. Semin Ophthalmol 37:136\u2013141. https:\/\/doi.org\/10.1080\/08820538.2021.1929347","journal-title":"Semin Ophthalmol"},{"key":"7039_CR20","doi-asserted-by":"publisher","first-page":"100261","DOI":"10.1016\/j.xops.2022.100261","volume":"3","author":"EY Chew","year":"2023","unstructured":"Chew EY, Peto T, Clemons TE et al (2023) Macular telangiectasia type 2: A classification system using multimodal imaging MacTel project report number 10. Ophthalmol Sci 3:100261. https:\/\/doi.org\/10.1016\/j.xops.2022.100261","journal-title":"Ophthalmol Sci"},{"key":"7039_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-73803-9","volume":"10","author":"YH Kim","year":"2020","unstructured":"Kim YH, Chung Y-R, Oh J et al (2020) Optical coherence tomographic features of macular telangiectasia type 2: Korean macular telangiectasia type 2 study\u2014report no. 1. Sci Rep 10:16594. https:\/\/doi.org\/10.1038\/s41598-020-73803-9","journal-title":"Sci Rep"},{"key":"7039_CR22","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3109\/09286580903450361","volume":"17","author":"TE Clemons","year":"2010","unstructured":"Clemons TE, Gillies MC, Chew EY et al (2010) Baseline characteristics of participants in the natural history study of macular telangiectasia (MacTel) MacTel project report no. 2. Ophthalmic Epidemiol 17:66\u201373. https:\/\/doi.org\/10.3109\/09286580903450361","journal-title":"Ophthalmic Epidemiol"},{"issue":"1","key":"7039_CR23","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1097\/IAE.0000000000001697","volume":"38","author":"T Peto","year":"2018","unstructured":"Peto T, Heeren TFC, Clemons TE et al (2018) Correlation of clinical and structural progression with visual acuity loss in macular telangiectasia type 2: MacTel project report no. 6-the MacTel research group. Retina 38(1):S8\u2013S13. https:\/\/doi.org\/10.1097\/IAE.0000000000001697","journal-title":"Retina"},{"key":"7039_CR24","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.2147\/OPTH.S373538","volume":"16","author":"KC Kedarisetti","year":"2022","unstructured":"Kedarisetti KC, Narayanan R, Stewart MW et al (2022) Macular telangiectasia type 2: A comprehensive review. Clin Ophthalmol Auckl NZ 16:3297\u20133309. https:\/\/doi.org\/10.2147\/OPTH.S373538","journal-title":"Clin Ophthalmol Auckl NZ"},{"key":"7039_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s40942-024-00545-5","author":"J Huemer","year":"2024","unstructured":"Huemer J, Heeren TF, Olvera-Barrios A et al (2024) Sight threatening diabetic retinopathy in patients with macular telangiectasia type 2. Int J Retina Vitreous. https:\/\/doi.org\/10.1186\/s40942-024-00545-5","journal-title":"Int J Retina Vitreous"},{"key":"7039_CR26","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.oret.2021.01.002","volume":"5","author":"SHM van Romunde","year":"2021","unstructured":"van Romunde SHM, van der Sommen CM, Martinez Ciriano JP et al (2021) Prevalence and severity of diabetic retinopathy in patients with macular telangiectasia type 2. Ophthalmol Retina 5:999\u20131004. https:\/\/doi.org\/10.1016\/j.oret.2021.01.002","journal-title":"Ophthalmol Retina"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-025-07039-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-025-07039-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-025-07039-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T10:13:07Z","timestamp":1772791987000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-025-07039-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["7039"],"URL":"https:\/\/doi.org\/10.1007\/s00417-025-07039-6","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"assertion":[{"value":"26 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This is a retrospective study involving patient data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"A \u201cwaiver of informed consent\u201d was obtained considering the retrospective nature of the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board of University of Pittsburgh and Narayana Nethralaya, Bangalore.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors have no conflict of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure of potential conflicts of interest"}}]}}